Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang   Wu Changgui   Li Zhikui   Bai Changqing  

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite

Moxifloxacin: A Review of its Clinical Potential in the Management of Community-Acquired Respiratory Tract Infections

By Barman Balfour J.A.   Lamb H.M.  

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 115-139

Adis International

Access to resources Recommend Favorite

Reducing morbidity in respiratory tract infections

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Azithromycin and lower respiratory tract infections

By Blasi F   Cazzola M   Tarsia P   Cosentini R   Aliberti S   Santus P   Allegra L  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2335-2351

Informa Healthcare

Access to resources Recommend Favorite

In Vitro and In Vivo Activity of Moxifloxacin against Community Respiratory Tract Pathogens

By Blondeau J.M.  

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 57-78

Adis International

Access to resources Recommend Favorite